Brandy Lloyd
Rheumatology · Amarillo, TXNPI 1598278475
Payments from drug & device makers
Across 983 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- UCB, Inc.$2K
- Johnson & Johnson$1K
- GSK$1K
- AstraZeneca$1K
- plus $7K from 25 others
What the payments were for
- Food & beverage$17,37998%
- Education$2992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 187 | $2,693 |
| AbbVie | 121 | $2,238 |
| UCB, Inc. | 96 | $2,098 |
| Johnson & Johnson(2 entities) | 72 | $1,269 |
| GSK | 64 | $1,238 |
| AstraZeneca(2 entities) | 65 | $1,161 |
| Pfizer | 54 | $867 |
| ANI Pharmaceuticals, Inc. | 34 | $718 |
| Novartis | 32 | $672 |
| Radius Health, Inc. | 36 | $586 |
| E.r. Squibb & Sons, L.L.C. | 41 | $548 |
| Aurinia Pharma U.S., Inc. | 29 | $516 |
| Lilly USA, LLC | 27 | $472 |
| Genentech USA, Inc. | 32 | $464 |
| Actelion Pharmaceuticals US, Inc. | 13 | $452 |
| Mallinckrodt Hospital Products Inc. | 17 | $405 |
| Boehringer Ingelheim | 18 | $339 |
| Organon | 14 | $255 |
| Sobi, Inc | 8 | $178 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Sanofi | 6 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Scilex Pharmaceuticals Inc. | 3 | $50 |
| Mylan Institutional Inc. | 2 | $34 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Sandoz | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,678 in reported general payments places this provider in the 65th percentile of 512 rheumatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xeljanz XrTofacitinib Citrate | 12 | $80,726 |
| Leflunomide | 158 | $7,702 |
| Colchicine | 118 | $7,376 |
| Hydroxychloroquine Sulfate | 227 | $6,843 |
| Celecoxib | 127 | $3,597 |
| Gabapentin | 277 | $3,508 |
| Sulfasalazine DrSulfasalazine | 86 | $3,129 |
| MethotrexateMethotrexate Sodium | 136 | $2,918 |
| Methocarbamol | 114 | $2,881 |
| Duloxetine Hcl | 83 | $2,374 |
| Mycophenolate Mofetil | 12 | $2,004 |
| Diclofenac Sodium | 93 | $1,621 |
| Prednisone | 209 | $1,549 |
| Sulfasalazine | 33 | $1,394 |
| Allopurinol | 138 | $1,131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Colchicine | $50 | $7,376118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 512 rheumatology providers in Texas.
Other rheumatology in Amarillo
- Constantine SaadehAmarillo$1.5M
- Nicole Davey-RanasingheAmarillo$658K
- Paul PickrellAustin$40.9M
- Atul SinghalMesquite$13.9M
- Shaikh AliTomball$9.8M
- Jitendra VasandaniLubbock$6.4M
- Dhiman BasuColleyville$6.2M
- Tamar BrionezThe Woodlands$5.2M
- Philip WallerHouston$4.9M
- John CushDallas$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.